These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 21979582)

  • 1. Conformation-dependent scFv antibodies specifically recognize the oligomers assembled from various amyloids and show colocalization of amyloid fibrils with oligomers in patients with amyloidoses.
    Zhang X; Sun XX; Xue D; Liu DG; Hu XY; Zhao M; Yang SG; Yang Y; Xia YJ; Wang Y; Liu RT
    Biochim Biophys Acta; 2011 Dec; 1814(12):1703-12. PubMed ID: 21979582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-amyloid oligomer specific scFv antibody attenuates memory deficits and brain amyloid burden in mice with Alzheimer's disease.
    Zhao M; Wang SW; Wang YJ; Zhang R; Li YN; Su YJ; Zhou WW; Yu XL; Liu RT
    Curr Alzheimer Res; 2014 Jan; 11(1):69-78. PubMed ID: 24156260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A scFv antibody targeting common oligomeric epitope has potential for treating several amyloidoses.
    Zha J; Liu XM; Zhu J; Liu SY; Lu S; Xu PX; Yu XL; Liu RT
    Sci Rep; 2016 Nov; 6():36631. PubMed ID: 27824125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformation-dependent single-chain variable fragment antibodies specifically recognize beta-amyloid oligomers.
    Wang XP; Zhang JH; Wang YJ; Feng Y; Zhang X; Sun XX; Li JL; Du XT; Lambert MP; Yang SG; Zhao M; Klein WL; Liu RT
    FEBS Lett; 2009 Feb; 583(3):579-84. PubMed ID: 19162022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.
    Salahuddin P; Fatima MT; Abdelhameed AS; Nusrat S; Khan RH
    Eur J Med Chem; 2016 May; 114():41-58. PubMed ID: 26974374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers.
    Kayed R; Head E; Sarsoza F; Saing T; Cotman CW; Necula M; Margol L; Wu J; Breydo L; Thompson JL; Rasool S; Gurlo T; Butler P; Glabe CG
    Mol Neurodegener; 2007 Sep; 2():18. PubMed ID: 17897471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural differences of amyloid-β fibrils revealed by antibodies from phage display.
    Droste P; Frenzel A; Steinwand M; Pelat T; Thullier P; Hust M; Lashuel H; Dübel S
    BMC Biotechnol; 2015 Jun; 15():57. PubMed ID: 26084577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Characteristics and Molecular Mechanism of a New scFv Antibody Against Aβ42 Oligomers and Immature Protofibrils.
    Zhang Y; Sun Y; Huai Y; Zhang YJ
    Mol Neurobiol; 2015 Dec; 52(3):1269-1281. PubMed ID: 25330935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anti-Aβ (amyloid β) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway.
    Marín-Argany M; Rivera-Hernández G; Martí J; Villegas S
    Biochem J; 2011 Jul; 437(1):25-34. PubMed ID: 21501114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel antibody against oligomeric amyloid-β: Insight into factors for effectively reducing the aggregation and cytotoxicity of amyloid-β aggregates.
    Zhang X; Huai Y; Cai J; Song C; Zhang Y
    Int Immunopharmacol; 2019 Feb; 67():176-185. PubMed ID: 30553911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology.
    Kumar ST; Jagannath S; Francois C; Vanderstichele H; Stoops E; Lashuel HA
    Neurobiol Dis; 2020 Dec; 146():105086. PubMed ID: 32971232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern recognition with a fibril-specific antibody fragment reveals the surface variability of natural amyloid fibrils.
    Haupt C; Bereza M; Kumar ST; Kieninger B; Morgado I; Hortschansky P; Fritz G; Röcken C; Horn U; Fändrich M
    J Mol Biol; 2011 May; 408(3):529-40. PubMed ID: 21376731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosetta Stone for Amyloid Fibrils: The Key Role of Ring-Like Oligomers in Amyloidogenesis.
    Galzitskaya OV; Selivanova OM
    J Alzheimers Dis; 2017; 59(3):785-795. PubMed ID: 28671122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.
    Glabe CG
    Neurobiol Aging; 2006 Apr; 27(4):570-5. PubMed ID: 16481071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer's disease and other diseases with amyloid deposits.
    Stefani M
    Prog Neurobiol; 2012 Dec; 99(3):226-45. PubMed ID: 22450705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligomers, protofibrils and amyloid fibrils from recombinant human lysozyme (rHL): fibrillation process and cytotoxicity evaluation for ARPE-19 cell line.
    Ruiz ED; Almada M; Burboa MG; Taboada P; Mosquera V; Valdez MA; Juárez J
    Colloids Surf B Biointerfaces; 2015 Feb; 126():335-43. PubMed ID: 25618793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformation-dependent anti-amyloid oligomer antibodies.
    Kayed R; Glabe CG
    Methods Enzymol; 2006; 413():326-44. PubMed ID: 17046404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.